The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?

C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

Eliminating cervical cancer: progress and challenges for high-income countries

JC Davies-Oliveira, MA Smith, S Grover, K Canfell… - Clinical Oncology, 2021 - Elsevier
Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

ETH Fontham, AMD Wolf, TR Church… - CA: a cancer journal …, 2020 - Wiley Online Library
Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …

KT Simms, J Steinberg, M Caruana, MA Smith… - The lancet …, 2019 - thelancet.com
Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

[HTML][HTML] The projected timeframe until cervical cancer elimination in Australia: a modelling study

MT Hall, KT Simms, JB Lew, MA Smith… - The Lancet Public …, 2019 - thelancet.com
Summary Background In 2007, Australia was one of the first countries to introduce a national
human papillomavirus (HPV) vaccination programme, and it has since achieved high …

[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - thelancet.com
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional …

K Kavanagh, KG Pollock, K Cuschieri… - The Lancet infectious …, 2017 - thelancet.com
Summary Background On Sept 1, 2008, Scotland launched routine vaccination for human
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment …

JB Lew, KT Simms, MA Smith, M Hall… - The Lancet Public …, 2017 - thelancet.com
Summary Background Australia's National Cervical Screening Program currently
recommends cytological screening every 2 years for women aged 18–69 years. Human …

Projected time to elimination of cervical cancer in the USA: a comparative modelling study

EA Burger, MA Smith, J Killen, S Sy… - The Lancet Public …, 2020 - thelancet.com
Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …